Which anaesthetic modality is to be avoided in sickle cell disease?
**Core Concept**
Sickle cell disease is a genetic disorder that affects hemoglobin production, leading to abnormal red blood cells. These cells can cause vaso-occlusive crises, which are painful episodes due to the sickling of red blood cells in small blood vessels. Anesthetists must choose an anesthetic modality that minimizes the risk of triggering a vaso-occlusive crisis.
**Why the Correct Answer is Right**
The correct answer is **Option B: Halothane**. Halothane is a halogenated anesthetic agent that can cause a decrease in deformability of red blood cells, making them more susceptible to sickling. This can trigger a vaso-occlusive crisis in patients with sickle cell disease. Halothane also affects the potassium channels in the red blood cells, which can lead to a decrease in 2,3-bisphosphoglycerate (2,3-BPG) levels. 2,3-BPG is an important regulator of hemoglobin function, and its decrease can further exacerbate sickling.
**Why Each Wrong Option is Incorrect**
* **Option A: Nitrous oxide** is not contraindicated in sickle cell disease. Nitrous oxide can actually help reduce the risk of vaso-occlusive crises by causing vasodilation and increasing blood flow to the affected areas.
* **Option C: Sevoflurane** is a commonly used anesthetic agent in patients with sickle cell disease. Sevoflurane does not have any known adverse effects on red blood cells and can be used safely in these patients.
**Clinical Pearl / High-Yield Fact**
When managing patients with sickle cell disease, anesthetists should avoid using halogenated anesthetic agents like halothane and instead opt for non-halogenated agents like sevoflurane or desflurane. Additionally, maintaining normothermia and avoiding hypoxia are crucial in preventing vaso-occlusive crises in these patients.
**Correct Answer: B. Halothane**